Lupin Receives US FDA Approval for Cefadroxil Capsules

Lupin Ltd on May 31, 2007 has announced that it has received approval from the US FDA for it's Abbreviated New Drug Application (ANDA) for Cefadroxil Capsules 500mg. Cefadroxil, a broad spectrum antibiotic, is used to treat infections caused by various bacteria.

The Company's Cefadroxil Capsules are the AB-rated generic equivalent of Warner Chilcott (erstwhile) Duricef® Capsules. This approval augments the cephalosporin portfolio of the Company in the $8.7 bn broad spectrum antibiotic market in the US.

With this approval, the Company now has 23 ANDAs approved by the US FDA.

Source : Equity Bulls

Keywords